Enzymatic Bioactivation
Enzymatic Bioactivation is the metabolic process by which an inactive bioprecursor prodrug is selectively converted into its pharmacologically active form through catalytic transformation by specific enzymes.
176
Publications
7K
Citations
730
Authors
220
Institutions
Publications per year
2017–2026
21
Parents
176
Lysostaphin: Enzymatic mode of action
Henry P. Browder, Walter A. Zygmunt, Jungmo Young et al. · Biochemical and Biophysical Research Communications · 1965 · 232 citations
1–5 of 176
730
6
h-index
5
h-index
4
h-index
3
h-index
3
h-index
1–5 of 730
220

University of Toronto
Toronto, Canada
8 h-index
27 publications
828 citations
University of California, Berkeley
Berkeley, United States
5 h-index
13 publications
541 citations
Pfizer (United States)
New York, United States
5 h-index
15 publications
811 citations

University of Minnesota
Minneapolis, United States
5 h-index
15 publications
403 citations

University of Liverpool
Liverpool, United Kingdom
5 h-index
23 publications
707 citations
Daiichi-Sankyo (Japan)
Tokyo, Japan
4 h-index
6 publications
171 citations
University of Washington
Seattle, United States
4 h-index
13 publications
231 citations
National University of Singapore
Singapore, Singapore
4 h-index
21 publications
334 citations
1–8 of 220
27 publications · 1K citations
19
h-index
23 publications · 871 citations
17
h-index
Repository · 6 publications · 445 citations
6
h-index
6 publications · 119 citations
6
h-index
6 publications · 287 citations
6
h-index
1–5